PL3027213T3 - Kompozycje do łagodzenia i/lub zapobiegania niepożądanym skutkom ubocznym w antybiotykoterapii - Google Patents

Kompozycje do łagodzenia i/lub zapobiegania niepożądanym skutkom ubocznym w antybiotykoterapii

Info

Publication number
PL3027213T3
PL3027213T3 PL14755588T PL14755588T PL3027213T3 PL 3027213 T3 PL3027213 T3 PL 3027213T3 PL 14755588 T PL14755588 T PL 14755588T PL 14755588 T PL14755588 T PL 14755588T PL 3027213 T3 PL3027213 T3 PL 3027213T3
Authority
PL
Poland
Prior art keywords
ameliorating
compositions
side effects
adverse side
antibiotic therapy
Prior art date
Application number
PL14755588T
Other languages
English (en)
Inventor
Martina Seibel
Peter Seibel
Original Assignee
Mitogenomix Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitogenomix Gmbh filed Critical Mitogenomix Gmbh
Publication of PL3027213T3 publication Critical patent/PL3027213T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL14755588T 2013-07-31 2014-07-27 Kompozycje do łagodzenia i/lub zapobiegania niepożądanym skutkom ubocznym w antybiotykoterapii PL3027213T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13003810.2A EP2832369A1 (en) 2013-07-31 2013-07-31 Compositions for ameliorating and/or preventing adverse side effects in antibiotic therapy
PCT/EP2014/002052 WO2015014470A1 (en) 2013-07-31 2014-07-27 Compositions for ameliorating and/or preventing adverse side effects in antibiotic therapy
EP14755588.2A EP3027213B1 (en) 2013-07-31 2014-07-27 Compositions for ameliorating and/or preventing adverse side effects in antibiotic therapy

Publications (1)

Publication Number Publication Date
PL3027213T3 true PL3027213T3 (pl) 2018-04-30

Family

ID=48914035

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14755588T PL3027213T3 (pl) 2013-07-31 2014-07-27 Kompozycje do łagodzenia i/lub zapobiegania niepożądanym skutkom ubocznym w antybiotykoterapii

Country Status (7)

Country Link
EP (2) EP2832369A1 (pl)
DK (1) DK3027213T3 (pl)
ES (1) ES2655566T3 (pl)
NO (1) NO3027213T3 (pl)
PL (1) PL3027213T3 (pl)
PT (1) PT3027213T (pl)
WO (1) WO2015014470A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104705289B (zh) * 2015-03-01 2016-08-24 安徽新生命干细胞科技有限公司 一种离体牙齿保存液
EP3970713A1 (en) 2020-09-16 2022-03-23 GV Squared S.r.l. Pharmaceutical composition comprising uridine and pyruvate for regulating the profileration, activity and survival of immune cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470838A (en) 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
US5633285A (en) * 1991-03-01 1997-05-27 Warner-Lambert Company Cytoprotective wound healing compositions and methods for preparing and using same
WO2007044700A2 (en) * 2005-10-07 2007-04-19 Board Of Trustees Of Southern Illinois University Protectant combinations for reducing toxicities
WO2013078554A1 (en) * 2011-12-02 2013-06-06 University Health Network Compositions of tigecycline and uses thereof
US20150071904A1 (en) * 2012-01-06 2015-03-12 Trustees Of Boston University Compositions and methods to boost endogenous ros production from bacteria

Also Published As

Publication number Publication date
EP3027213A1 (en) 2016-06-08
EP2832369A1 (en) 2015-02-04
WO2015014470A1 (en) 2015-02-05
DK3027213T3 (en) 2018-01-15
PT3027213T (pt) 2018-01-19
NO3027213T3 (pl) 2018-03-17
EP3027213B1 (en) 2017-10-18
ES2655566T3 (es) 2018-02-20

Similar Documents

Publication Publication Date Title
HK1226301A1 (zh) 修飾的治療劑及其組合物
HK1217651A1 (zh) 固溶體組合物及其在劇痛中的用途
IL286759A (en) Therapeutic methods and preparations
HK1216175A1 (zh) 治療性化合物和組合物
GB201317286D0 (en) Composition and Use
HK1220920A1 (zh) 治療性組合物和其用途
HK1217650A1 (zh) 用於治療劇痛的組合物及方法
PL3057441T3 (pl) Kompozycja do zapobiegania martwiczego zapalenia jelit u ptactwa z nadrzędu Galloanserae
ZA201603240B (en) Synergistic pesticidal compositions and related methods
ZA201603225B (en) Synergistic pesticidal compositions and related methods
ZA201603228B (en) Synergistic pesticidal compositions and related methods
ZA201603235B (en) Synergistic pesticidal compositions and related methods
HK1222561A1 (zh) 用於腫瘤學的組合物和方法
EP2968374A4 (en) METHODS AND COMPOSITIONS FOR IMPROVING OXYGEN RATE IN FABRICS
IL242584B (en) An immunogenic preparation for use in treatment
ZA201603224B (en) Synergistic pesticidal compositions and related methods
PT3027213T (pt) Composições para melhorar e/ou prevenir efeitos colaterais adversos em antibioterapia
ZA201603234B (en) Synergistic pesticidal compositions and related methods
GB201308753D0 (en) Compounds and their use in therapy
IL243091B (en) Compositions and methods for use in oncology
ZA201508585B (en) Immunogenic composition for use in therapy
GB201304675D0 (en) Novel compositions having use in therapy
GB201319255D0 (en) Therapeutic compositions and methods
GB201314623D0 (en) Novel mucinase for use in therapy or prophylaxis
GB201308217D0 (en) Compounds and their use in therapy